Author: Purple Foxy

Creator of wearable sustained acoustic medicine technology to educate clinicians on device’s effectiveness in soft tissue healing and regenerative medicine treatment.

sam\u00aex1
sam\u00aex1

LAS VEGAS, January 26, 2023 (Newswire.com)
–
ZetrOZ Systems will demonstrate the effectiveness of its sam®x1 and sam®2.0 sustained acoustic medicine devices for soft tissue injury therapies at the Las Vegas Regenerative Medicine and MSK Ultrasound Course, the longest-running medical education seminar of its kind, from Jan. 26 to 28 in Las Vegas.

The sam®x1 is the first FDA-cleared pain management device of its kind cleared for everyday, at-home use, and the sam®2.0 is the long-duration solution. Both are wearable pain relief ultrasound devices that inhibit inflammation and accelerate natural healing by stimulating tissue regeneration, increasing circulation, and nutrient exchange in deep musculoskeletal tissue.

The multiple-day educational course, at the Planet Hollywood Resort and Casino, Las Vegas, welcomes hundreds of practitioners as varied as orthopedic surgeons, sports medicine physicians, PM&R physicians, pain management physicians, interventional radiologists, rheumatologists, physical therapists, naturopathic doctors, chiropractors, podiatrists, physician assistants, nurse practitioners, diagnostic sonographers and more.

“The Las Vegas Regenerative Medicine and MSK Ultrasound Course brings in leading physicians and other practitioners who will speak on the administration of ultrasound technology and its many benefits – it offers patients options beyond pain medication or surgery,” says Dr. George Lewis, founder and CEO of ZetrOZ Systems. “We’re incredibly excited to attend and bring awareness of our innovative pain relief ultrasound device portfolio to more healthcare professionals.”

The first day of the program will be dedicated to reviewing scientific updates, new regulations, and best practices of the orthopedic discipline. The last two days will focus on practical ultrasound operation, and ZetrOZ Systems sam®x1 and sam®2.0 will be joining the lineup of medical treatment options available for clinicians to review and apply.

Backed by more than 30 clinical studies, sam® technology was developed with research funded by the National Institutes of Health and the U.S. Department of Defense with the intent of finding new methods of soft tissue healing that reduce the use of narcotics and invasive treatments.

To learn more about sustained acoustic medicine and its effectiveness in soft tissue healing, visit zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.

Contact Information:

Buse Kayar

buse@newswire.com

Original Source:

ZetrOZ Systems to Showcase New Soft Tissue Healing Innovations sam®x1 and sam®2.0 Technologies at Regenerative and Musculoskeletal Ultrasound Course

Call for pediatric involvement in primary prevention to address sexual victimization of children. Over 90% of parents agree that pediatricians should be discussing sexual abuse prevention with the families they serve.
…

Academic Urology Research Investigators Consortium AURIC Logo

SARATOGA SPRINGS, N.Y., January 26, 2023 (Newswire.com)
–
Criterium, Inc., a full-servic…

SpendMend sets company growth records in 2022 while receiving multiple strategic investments and completing multiple acquisitions.

SpendMend Spen…

WAYNE, Pa., January 26, 2023 (Newswire.com)
–
McBee®, an industry-leading healthcare services and consulting firm, advised The Care Team (TCT) on the acq…

Dr. Vinson Eugene Allen and his wife, Dr. Connie Yu, have named the Hand-Up program in honor of their son Colin Mathew Allen

The Allen Family Dr….

HITRUST Risk-based, 2-year Certification validates SmartStory is committed to meeting key regulations and protecting sensitive information.

SmartSt…

Higher Learning Technologies and Derm for Primary Care will work together to make their top-rated educational content accessible to more learners

…

GI Research Foundation Logo

CHICAGO, January 24, 2023 (Newswire.com)
–
Treating and curing cancer remains an urgent health research priority. The Gastr…

Panoramic Health Triples Number of Medicare Patients Under Care Across 18 KCEs in 14 States During Tremendous Growth Year

TEMPE, Ariz., January 24, 2023 (Newswire.com)
–
Panoramic Health℠, the leading integrated value-based kidney care platform in the country, announced significant growth as a participant in Medicare’s Comprehensive Kidney Care Contracting (CKCC) program within the Kidney Care Choices Model.

In its commitment to improving outcomes and access to holistic care coordination at reduced costs for patients suffering from CKD-ESKD, Panoramic Health tripled the number of aligned Medicare beneficiaries under its care to more than 27,000 patients and added 14 new Kidney Contracting Entities (KCEs) for the 2023 CKCC Performance Year. Panoramic Health is the largest CKCC participant not affiliated with a Large Dialysis Organization (LDO), accounting for nearly 40% of non-LDO lives in Professional and Global CKCC program options. Panoramic Health kicks off 2023 supporting 18 KCEs total, 14 KCEs in the highest tier Global Risk Option and 4 KCEs in the Professional Model.

The Panoramic Health platform drives improved outcomes and lowers the total cost of care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) through unparalleled integration and alignment with nephrology practices, holistic approach to patient care across sites of service, and advanced data and analytics. The integrated capabilities and superior care coordination slow disease progression through data-driven early intervention, improve CKD management, increase optimal dialysis transitions, reduce hospitalizations, and lower hospital readmissions.

“Our remarkable growth in the CKCC program last year is a testament to the unique capabilities that position Panoramic Health’s platform as the superior value-based kidney care platform for patients, providers, and payers,” said Rajiv Poduval, M.D., FASN, CEO and co-founder of Panoramic Health. “I look forward to another year of growth as we keep nephrologists at the helm of care delivery and further our mission to transform kidney care to better serve patients with CKD and ESKD.”

Panoramic Health’s novel approach to value-based patient care coordination puts nephrologists at the forefront of care delivery, leading to patient engagement rates above 70%, 2-3 times greater than non-nephrologist-led care coordination vendors. In 2022, when looking at patients in the top half of the population for clinical complexity, engaged patients saw as high as 36% fewer admissions and 22% fewer readmissions compared to non-engaged peers, which is attributable to the unique physician-led model. This engagement also led to a rate of planned dialysis starts in the top quartile of all providers nationally compared to Medicare-published benchmarks.

“Panoramic Health’s distinct value-based care capabilities drive superior patient engagement rates, optimal starts, and reduced hospitalizations, ultimately delivering better outcomes for patients with CKD and ESKD,” said Dave Miller, Vice President of Value-Based Care. “Our physician-led care model allows us to implement improved care coordination at every level, as we have a direct connection to the patient-provider relationship which is integral in empowering patients to take an active role in their care plans.”

The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.

About Panoramic Health

Panoramic Health is the nation’s leading integrated physician-led value-based kidney care organization. The company remains committed to keeping nephrologists independent, relevant, and at the center of patient-care delivery. Panoramic Health’s value-based care delivery platform is driven by proprietary, predictive data analytics and clinical workflows underpinned by one of the world’s largest clinical chronic kidney disease (“CKD”) data warehouses that enable nephrologists to deliver better patient outcomes through value-based care and clinical research. Panoramic Health’s Clinical Research division partners with sponsors and clinical research organizations to bring cutting-edge treatments to patients with kidney disease. For more information, visit panoramichealth.com.

For press inquiries, please contact media@panoramichealth.com. 

Contact Information:

Panoramic Health Media

media@panoramichealth.com

Original Source:

Panoramic Health Solidifies Position as Largest Physician-Led Participant in Medicare’s Kidney Care Choices Model